Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.350 +0.020 (+1.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
INO Stock: The Covid-19 Vaccine News Helping Inovio Power Higher ↗
Inovio Pharmaceuticals (INO) stock is pushing higher on Tuesday after providing investors with an update on its Covid-19 vaccine. 
Via InvestorPlace
News headline image
FDA Lifts Clinical Hold On Inovio's COVID-19 Vaccine Trial ↗
The FDA has lifted a partial clinical hold on a late-stage trial of Inovio Pharmaceuticals Inc's (NASDAQ: INO) COVID-19 vaccine in the U.S. Inovio said it... 
Via Benzinga
Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the... 
Via FinancialNewsMedia
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
News headline image
AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio ↗
MedImmune Limited, a unit of AstraZeneca Plc (NASDAQ: AZN), has notified Inovio Pharmaceuticals Inc (NASDAQ: INO) to terminate the DNA cancer vaccine... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
News headline image
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage ↗
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral... 
Via Talk Markets
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing... 
Via FinancialNewsMedia
News headline image
Is This The Turning Point for Inovio? ↗
The biotech's streak of bad luck may be about to end, but risks remain. 
Via The Motley Fool
New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in... 
Via FinancialNewsMedia
News headline image
Is Vaccine Latecomer Inovio Making a Comeback? ↗
Its new plan for phase 3 trials is advancing. 
Via The Motley Fool
As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024
Via FinancialNewsMedia
News headline image
Looking Into Inovio Pharmaceuticals's Return On Capital Employed ↗
Inovio Pharmaceuticals (NASDAQ:INO) brought in sales totaling $272.82 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 58.32%, resulting... 
Via Benzinga
News headline image
Etsy And NetApp Lead The S&P 500 ↗
U.S. indices were trading lower Thursday as traders await signs of Fed tapering policy. Explosions outside of Kabul airport in Afghanistan has also caused macro uncertainty and... 
Via Benzinga
Topics Economy Stocks
News headline image
Why Inovio Stock Is Jumping Today ↗
The vaccine maker received some good news from Brazil. 
Via The Motley Fool
News headline image
Inovio Pharmaceuticals Stock Nears End Of Technical Pattern ↗
Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares are trading... 
Via Benzinga
News headline image
Inovio To Start Global Late-Stage COVID-19 Vaccine Trial ↗
The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-... 
Via Benzinga
News headline image
Why Inovio's Stock Is Trading Higher Today ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the... 
Via Benzinga
News headline image
2 Popular Robinhood Stocks I Wouldn't Buy With Free Money ↗
Not every stock on the popular trading app is worth owning. 
Via The Motley Fool
News headline image
Why Dynavax, Novavax, and Inovio Stocks Sank This Week ↗
Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines. 
Via The Motley Fool
News headline image
Unusual Options Activity Insight: Inovio Pharmaceuticals ↗
On Wednesday, shares of Inovio Pharmaceuticals (NASDAQ:INO) saw unusual options activity. After the option alert, the stock price moved down to $8.29. Sentiment: BULLISH Option... 
Via Benzinga
News headline image
3 Scary COVID Stocks to Avoid ↗
Our Fool roundtable picks three COVID stocks they think are dangerous at these prices. 
Via The Motley Fool
News headline image
Apple And Salesforce Lead The DIA In A Mixed Day Of Trading ↗
U.S. indices had a mixed day of trading Thursday as traders and investors weigh COVID-19 variant updates, recent earnings and the recently passed $1 trillion... 
Via Benzinga
News headline image
77 Biggest Movers From Yesterday ↗
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
News headline image
Watch Out: Inovio Pharmaceuticals Is Heating Up ↗
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday alongside other vaccine maker stocks. Stocks have been trading higher recently as the COVIS-19 delta... 
Via Benzinga
News headline image
85 Biggest Movers From Yesterday ↗
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX... 
Via Benzinga
News headline image
Why Inovio Pharmaceuticals Is Plunging Today ↗
Solid business developments did not please investors. 
Via The Motley Fool
News headline image
Why Inovio's Stock Is Trading Lower Today ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading lower by 9.9% at $8.65 after the company reported worse-than-expected second-quarter EPS and sales results.... 
Via Benzinga
News headline image
54 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy... 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.